Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model

Lung cancer is the leading cause of cancer-related death. About 80% of lung cancers are non–small cell lung cancers (NSCLC). Radiotherapy is widely used in treatment of NSCLC. However, the outcome of NSCLC remains unsatisfactory. In this study, a vascular disrupting agent (VDA) combretastatin-A4-pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuejiao, Jiang, Cuihua, Zhang, Dongjian, Gao, Meng, Peng, Fei, Huang, Dejian, Sun, Ziping, Ni, Yicheng, Zhang, Jian, Yin, Zhiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694910/
https://www.ncbi.nlm.nih.gov/pubmed/26305548

Ejemplares similares

Ejemplares similares